Minerva Neuroscience has raised $200M in total funding. Latest round: Growth. Backed by Vivo Capital LLC, Janus Henderson Investors.
Minerva Neuroscience funding overview
Minerva Neuroscience has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in October 2025. The round record for Minerva Neuroscience runs through 2025; nothing later has been disclosed. Investors on record include Vivo Capital LLC, Janus Henderson Investors, Federated Hermes Kaufmann Funds, Farallon Capital Management, Coastlands Capital, Balyasny Asset Management and 6 others. 12 distinct backers are named across the disclosed rounds.
Minerva Neuroscience at a glance
Total raised
$200M
Latest round
Growth
Latest round date
October 2025
Notable investors
Vivo Capital LLC, Janus Henderson Investors, Federated Hermes Kaufmann Funds, Farallon Capital Management, Coastlands Capital, Balyasny Asset Management, Logos Capital, BSQUARED Capital
Frequently asked about Minerva Neuroscience funding
How much has Minerva Neuroscience raised?
Minerva Neuroscience has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Minerva Neuroscience?
Vivo Capital LLC, Janus Henderson Investors, Federated Hermes Kaufmann Funds, Farallon Capital Management, Coastlands Capital, Balyasny Asset Management are named among the investors backing Minerva Neuroscience.
What was the latest Minerva Neuroscience funding round?
The most recent disclosed round is a Growth, announced in October 2025.
Where is Minerva Neuroscience based?
No headquarters location is disclosed for Minerva Neuroscience.
When did Minerva Neuroscience last raise?
The last disclosed Minerva Neuroscience round closed in October 2025 at Growth.
Totals shown for Minerva Neuroscience aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
